Procter & Gamble Company (The) $PG Shares Sold by Commerzbank Aktiengesellschaft FI

Commerzbank Aktiengesellschaft FI lessened its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 8.0% during the 3rd quarter, Holdings Channel reports. The firm owned 574,956 shares of the company’s stock after selling 50,243 shares during the quarter. Procter & Gamble comprises 1.8% of Commerzbank Aktiengesellschaft FI’s portfolio, making the stock its 18th largest holding. Commerzbank Aktiengesellschaft FI’s holdings in Procter & Gamble were worth $88,342,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Halbert Hargrove Global Advisors LLC purchased a new position in Procter & Gamble during the 3rd quarter worth approximately $25,000. Signature Resources Capital Management LLC increased its stake in shares of Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after acquiring an additional 72 shares during the period. Corundum Trust Company INC purchased a new position in shares of Procter & Gamble during the third quarter worth $32,000. Mid American Wealth Advisory Group Inc. purchased a new stake in Procter & Gamble in the second quarter valued at $34,000. Finally, RMG Wealth Management LLC purchased a new stake in shares of Procter & Gamble in the second quarter worth about $37,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Stock Up 0.2%

PG stock opened at $150.19 on Friday. The firm has a market cap of $350.95 billion, a PE ratio of 22.25, a PEG ratio of 5.07 and a beta of 0.39. Procter & Gamble Company has a one year low of $137.62 and a one year high of $179.99. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.51 and a current ratio of 0.72. The firm’s 50 day moving average price is $144.72 and its 200-day moving average price is $150.54.

Procter & Gamble (NYSE:PG) last posted its earnings results on Thursday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.02. The company had revenue of $22.21 billion during the quarter, compared to analysts’ expectations of $22.36 billion. Procter & Gamble had a return on equity of 32.10% and a net margin of 19.30%.The firm’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.88 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 17th. Investors of record on Friday, January 23rd will be given a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble’s dividend payout ratio (DPR) is presently 62.67%.

Insider Buying and Selling

In other news, CAO Matthew W. Janzaruk sold 725 shares of the firm’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $149.57, for a total transaction of $108,438.25. Following the completion of the transaction, the chief accounting officer directly owned 979 shares in the company, valued at $146,429.03. This trade represents a 42.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.20% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. raised shares of Procter & Gamble from a “neutral” rating to an “overweight” rating and lifted their target price for the company from $157.00 to $165.00 in a report on Friday. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Procter & Gamble from $176.00 to $171.00 and set a “buy” rating for the company in a research report on Monday, December 8th. Bank of America reduced their target price on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Wells Fargo & Company lifted their price target on Procter & Gamble from $158.00 to $165.00 and gave the stock an “overweight” rating in a research note on Friday. Finally, Jefferies Financial Group raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and raised their price target for the stock from $156.00 to $179.00 in a research note on Tuesday, December 16th. Fourteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $166.70.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Q2 EPS beat and guidance maintained — P&G reported adjusted EPS of $1.88, topping estimates and reiterating FY2026 EPS guidance, which supports the company’s cash-return profile and dividend reliability. Procter & Gamble Q2 Earnings Beat Estimates, Organic Sales Flat Y/Y
• Positive Sentiment: JPMorgan upgrade lifts sentiment — JPMorgan moved PG from Neutral to Overweight and raised its $165 price target, giving the stock renewed upward momentum from the buy-side. JPMorgan Upgrade
• Positive Sentiment: Unusually large call buying suggests short-term bullish positioning — heavy call-option volume (241k contracts) points to investor speculation on upside around the earnings/news flow (could amplify near-term moves).
• Neutral Sentiment: Innovation initiatives (premium diapers in China) are longer-term growth plays — P&G is pushing Pampers Prestige (silk fibers) to capture premium demand in China; useful for future mix improvement but not an immediate revenue cure. Procter & Gamble is selling diapers made with silk fibers in China as it leans into luxury
• Neutral Sentiment: Management emphasizing data & technology-led reinvention — new CEO/President highlighted investments to improve targeting and margins; positive strategically but execution will take quarters. Procter & Gamble Says Data and Technology Will Support Company’s Reinvention
• Negative Sentiment: Revenue came up short and organic sales were flat — top-line missed consensus as volumes declined in key categories (razors, diapers) and pricing/mix only partly offset weakness, which is why some investors sold into the print. Procter & Gamble misses revenue estimates due to slower US growth
• Negative Sentiment: Tariff/geopolitical and consumer headwinds flagged — management warned of a challenging external environment (tariffs, geopolitical risk) that could pressure volumes and margins, creating near-term uncertainty. Procter & Gamble falls after warning of challenging consumer and geopolitical environment
• Negative Sentiment: Investor reaction remains mixed — analysts raised some forecasts, but coverage notes the quarter was “mixed” (EPS beat, revenue miss, flat organic sales), so expect muted trading and volatility as the market digests forward commentary. How Investors Are Reacting To Procter & Gamble (PG) Steady Earnings, Softer Guidance And Flat Organic Sales

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.